Summarized by Plex Health
Last Updated: 02 May 2022
infantile hemangioma in a v2 distribution: treatment with nadolol. "infantile hemangioma in a v2 distribution: treatment with nadolol.", by Giberson M, Hayes R. F1: (a) Patient at 11 weeks of age, before receiving nadolol treatment. (b) Patient at 21 weeks of age, after 10 weeks of treatment...

Nadolol tablets, USP are an artificial nonselective beta-adrenergic receptor obstructing agent marked chemically as 1-3 [oxy] -2 propanol. Nadolol might also be used for other objectives not detailed in this medicine guide. You must not use nadolol if you have bronchial asthma, a significant heart disease, serious cardiac arrest, or if your heart can not pump blood correctly. It is not recognized whether nadolol will hurt a coming infant. If the mother takes the medication during maternity, nadolol may cause heart or lung troubles in a newborn. Tell your medical professional if you are pregnant or plan to come to be pregnant while making use of nadolol. Nadolol can pass into breast milk and might damage a nursing baby. Your medical professional may periodically change your dose to make sure you get the best outcomes. Do not use nadolol in bigger or smaller sized quantities or for longer than advised. Do not miss doses or quit utilizing nadolol suddenly. Quiting suddenly may make your problem even worse. Your blood pressure will require to be checked often. Inform any physician that treats you that you are utilizing nadolol. Keep utilizing this medication even if you really feel well if you are being treated for high blood pressure. High blood pressure often has no symptoms. You may need to use blood pressure medicine for the remainder of your life. Nadolol is only part of a full program of therapy for hypertension that might include weight, diet regimen, and exercise control. Avoid the missed out on dose if your next dose is less than 8 hours away.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
39147C17H27NO4309.4CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)OCC(C)(C)NCC(COC1=CC=CC2=C1C[[email protected]@H]([[email protected]@H](C2)O)O)OInChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1VWPOSFSPZNDTMJ-UCWKZMIHSA-N(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol0.7309.19400834309.194008348234404562203210001
*** If you want us to remove all links leading to your domain from and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.